Literature DB >> 13652127

Structure-activity relationships and cross-resistance observed on evaluation of a series of purine analogs against experimental neoplasms.

H E SKIPPER, J A MONTGOMERY, J R THOMSON, F M SCHABEL.   

Abstract

Entities:  

Keywords:  CYTOTOXIC DRUGS; PURINES/effects

Mesh：

Substances：

Year:  1959        PMID： 13652127

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  6 in total

1.  Specific Targeting of MTAP-Deleted Tumors with a Combination of 2'-Fluoroadenine and 5'-Methylthioadenosine.

Authors:  Baiqing Tang; Hyung-Ok Lee; Serim S An; Kathy Q Cai; Warren D Kruger
Journal:  Cancer Res       Date:  2018-05-29       Impact factor: 12.701

Review 2.  Cellular and clinical pharmacology of fludarabine.

Authors:  Varsha Gandhi; William Plunkett
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 3.  Anti-cancer activities of Schedule E1 drugs used in ayurvedic formulations.

Authors:  E N T Vikram; R Ilavarasan; R Kamaraj
Journal:  J Ayurveda Integr Med       Date:  2022-05-31

4.  Use of E. coli Purine Nucleoside Phosphorylase in the Treatment of Solid Tumors.

Authors:  William B Parker; Eric J Sorscher
Journal:  Curr Pharm Des       Date:  2017-11-08       Impact factor: 3.116

5.  Isolation of isoguanosine from Croton tiglium and its antitumor activity.

Authors:  J H Kim; S J Lee; Y B Han; J J Moon; J B Kim
Journal:  Arch Pharm Res       Date:  1994-04       Impact factor: 4.946

Review 6.  Evolution of the arabinosides and the pharmacology of fludarabine.

Authors:  W Plunkett; V Gandhi
Journal:  Drugs       Date:  1994       Impact factor: 9.546
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.